Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

被引：0
|
作者：
Schwartz, G
Chu, QSC
Hammond, LA
Mita, M
Curtright, J
Versola, MJ
Koch, K
Pandite, LN
Ho, PTC
Rowinsky, EK
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
[2] Inst Drug Dev, San Antonio, TX USA
[3] GlaxoSmithKline, Res Triangle Pk, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3070
引用
收藏
页码：212S / 212S
页数：1
相关论文
共 50 条
  • [1] A phase I study of GW572016 in patients with solid tumors
    Minami, H
    Nakagawa, K
    Kawada, K
    Mukai, H
    Tahara, M
    Kurata, T
    Uejima, H
    Nogami, T
    Sasaki, Y
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 207S - 207S
  • [2] A phase I study of lapatinib (GW572016) and topotecan in patients with solid tumors
    Molina, JRM
    Adjei, AA
    Erlichman, C
    Mandrekar, S
    Joy, ME
    Rubin, SD
    Reid, J
    ANNALS OF ONCOLOGY, 2006, 17 : 49 - 49
  • [3] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [4] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk L.C.
    Vasey P.
    Sparreboom A.
    Reigner B.
    Planting A.S.Th.
    Gordon R.J.
    Osterwalder B.
    Verweij J.
    Twelves C.
    British Journal of Cancer, 2000, 83 (1) : 22 - 29
  • [5] Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies
    Chu, Quincy S. C.
    Schwartz, Garry
    de Bono, Johann
    Smith, Deborah A.
    Koch, Kevin M.
    Versola, Melissa J.
    Pandite, Lini
    Arya, Nikita
    Curtright, Jan
    Fleming, Ronald A.
    Ho, Peter T. C.
    Rowinsky, Eric K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3753 - 3758
  • [6] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk, LC
    Vasey, P
    Sparreboom, A
    Reigner, B
    Planting, AST
    Gordon, RJ
    Osterwalder, B
    Verweij, J
    Twelves, C
    BRITISH JOURNAL OF CANCER, 2000, 83 (01) : 22 - 29
  • [7] A phase I study of Lapatinib (GW572016) and topotecan in patients with solid tumors.
    Erlichman, C
    Adjei, AA
    Joy, ME
    Rubin, SD
    Friedman, RA
    Ames, MM
    Reid, JM
    Molina, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8994S - 8994S
  • [8] Phase I clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumors.
    Alexandre, J
    Tchen, N
    Berthault-Cvitkovic, F
    Misset, JL
    Benettaib, B
    Kahatt, C
    Raymond, E
    Weems, G
    MacDonald, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9057S
  • [9] Phase I and pharmacokinetic study of everolimus and capecitabine in patients with solid tumors
    Wilmink, J.
    Deenen, M. J.
    Klumpen, H.
    Sparidans, R.
    Beijnen, J.
    Schellens, J. H.
    Richel, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors
    Siegel-Lakhai, Wandena S.
    Beijnen, Jos H.
    Vervenne, Walter L.
    Boot, Henk
    Keessen, Marianne
    Versola, Melissa
    Koch, Kevin M.
    Smith, Deborah A.
    Pandite, Lini
    Richel, Dirk J.
    Schellens, Jan H. M.
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4495 - 4502
12345